OOIR: Observatory of International Research

Papers

(The TQCC of Heart Rhythm is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
Implantable cardioverter-defibrillators for primary prevention during or early after hospitalization? A time to pause, reflect, and exercise sound clinical judgment	431
ID: 4121707 The Benefit of Signal Quality Assessment in Automated Ventricular Ectopic Beat Detection	206
Decisional conflict and defibrillator implantation choices among Black women and men with chronic systolic heart failure	168
Outcome of cardiac implantable electronic devices in pediatric heart transplant recipients	136
To the Editor — Ganglionated plexus modulation inducing vagal response during pulsed field ablation for atrial fibrillation: A blessing in disguise	130
Efficacy and safety of once-daily carvedilol in patients with atrial fibrillation: A randomized, double-blind, placebo-controlled trial	122
PO-04-066 DESIGN AND PRE-CLINICAL ASSESSMENT OF A NOVEL RETROGRADE AORTIC DELIVERY SHEATH TO AID ACCESS FOR LEFT VENTRICULAR MAPPING AND ABLATION	114
PO-04-170 AUTOMATED CT-BASED PREDICTION OF VENTRICULAR ARRHYTHMIA	105
PO-03-146 PREMATURE VENTRICULAR CONTRACTIONS IN CHILDREN AND YOUNG ADULTS: RISK FACTORS FOR LEFT VENTRICULAR DYSFUNCTION	96
CI-452767-3 MACHINE LEARNING-POWERED, DEVICE-EMBEDDED HEART SOUND MEASUREMENT CAN OPTIMIZE AV DELAY IN CRT PATIENTS	90
PO-02-216 SEGMENTAL INCREASE IN HETEROGENEITY OF REPOLARIZATION CORRESPONDS TO REGIONS OF DECREASED INNERVATION AFTER MYOCARDIAL INFARCTION	87
PO-05-119 PEAK FREQUENCY CAN BE EFFECTIVELY USED TO CHARACTERIZE ATRIAL REMODELING IN ATRIAL FIBRILLATION	85
PO-04-196 CORRELATION BETWEEN VENTRICULAR TACHYCARDIA CIRCUIT AND CARDIAC COMPUTED TOMOGRAPHY-DERIVED WALL THINNING FOR POSTINFARCTION VENTRICULAR TACHYCARDIA ABLATION	83
PO-01-043 COMPARISON OF RISK SCORES FOR PREDICTION OF SUDDEN DEATH AND SUSTAINED VENTRICULAR TACHYCARDIA IN REPAIRED TETRALOGY OF FALLOT	82
PO-01-141 REAL LIFE EXPERIENCE WITH PULSED FIELD ABLATION FOR RECURRENT VENTRICULAR ARRHYTHMIAS	67
PO-01-065 DECREASE IN HEART RATE AND BRADYCARDIA PRECEDING IN-HOSPITAL CARDIAC ARREST	66
PO-01-019 VASCULAR AGE PREDICTION USING CHEST X-RAYS	64
PO-04-122 PULSED FIELD ABLATION DOSE-RESPONSE SAFETY AND EFFICACY CHARACTERIZATION OF A NOVEL LARGE SPHERICAL TIP MAPPING AND CONTACT FORCE-SENSING CATHETER	56
PO-04-064 INVASIVE HAEMODYNAMIC ASSESSMENT SHOWS THE OBESITY-HFPEF PHENOTYPE IS COMMON AMONGST PATIENTS WITH SYMPTOMATIC AF	55
PO-01-079 SEX DIFFERENCES IN ELECTROGRAPHIC FLOW PHENOTYPES AND OUTCOMES IN PATIENTS UNDERGOING PULMONARY VEIN ISOLATION	53
PO-03-160 IS THERE A FUTURE FOR THE 90-DAY BLANKING PERIOD AFTER PULSED FIELD ABLATION: EARLY RECURRENCES IN THE PULSED AF TRIAL	53
PO-02-144 LEFT ATRIAL FUNCTIONAL AND TISSUE CHANGES AFTER PULMONARY VEIN ISOLATION IN ATRIAL FIBRILLATION PATIENTS - INITIAL RESULTS OF THE EVALUATE-PVI STUDY	50
PO-01-026 RIGHT ATRIAL APPENDAGE THROMBECTOMY USING ALPHAVAC TO FACILITATE ATRIAL FIBRILLATION (AFIB) ABLATION	50
PO-02-140 WITHDRAWN	50
PO-01-093 PREDICTORS OF ARRHYTHMIA IN THE INPATIENT POPULATION PRIMARILY HOSPITALIZED FOR SARS-COV-2; A RETROSPECTIVE LARGE-DATABASE ANALYSIS	50

PO-03-174 PREDICTORS OF PERMANENT PACEMAKER PLACEMENT IN PATIENTS UNDERGOING TRICUSPID VALVE SURGERY-A RETROSPECTIVE COHORT STUDY OF THE NATIONAL INPATIENT SAMPLE	49
MP-483499-007 MECHANISMS OF MITRAL ISTHMUS RECONNECTION AFTER MITRAL ISTHMUS ABLATION WITH AND WITHOUT VEIN OF MARSHALL ETHANOL INFUSION	48
PO-03-192 THE ASSOCIATION BETWEEN PACED LEFT VENTRICULAR ACTIVATION TIME AND CARDIAC REVERSE REMODELING IN HEART FAILURE PATIENTS WITH LEFT BUNDLE BRANCH BLOCK	47
PO-03-171 LEADLESS PACEMAKERS ARE UNAFFECTED BY RADIATION EXPOSURE AT CLINICALLY RELEVANT THERAPEUTIC DOSES USED IN ONCOLOGY	46
PO-02-192 FIRST REPORT OF STRENGTH-DURATION CURVES OBTAINED FROM PATIENTS IMPLANTED WITH A NOVEL DUAL-CHAMBER LEADLESS PACEMAKER SYSTEM	44
PO-02-064 IS THORACIC IMPEDANCE TRULY ACCURATE IN PREDICTING ACUTE DECOMPENSATIONS ACROSS DIFFERENT STAGES OF HEART FAILURE?	44
PO-01-036 ACCURACY OF FORWARD-SOLUTION COMPUTATIONAL ECG MAPPING FOR VENTRICULAR ARRHYTHMIAS IN PATIENTS WITH ADULT CONGENITAL HEART DISEASE	43
PO-03-164 INCIDENCE, PREDICTORS, AND INDICATIONS FOR PERMANENT PACEMAKER IMPLANTATION AFTER ORTHOTOPIC HEART TRANSPLANTATION	43
PO-02-069 OUTCOMES OF LEFT BUNDLE BRANCH AREA PACING UPGRADE IN PATIENTS WITH RIGHT VENTRICULAR PACING-INDUCED CARDIOMYOPATHY	43
PO-02-184 IMCAP-AI STUDY: EVALUATION OF THE DIAGNOSTIC PERFORMANCE AND ORGANIZATIONAL IMPACT OF AN ILR ECG ANALYZER ALGORITHM IN CLINICAL PRACTICE	41
MP-483492-003 SHORTER COUPLED PREMATURE ATRIAL COMPLEXES LEAD TO ACUTE ATRIAL MECHANICAL DYSFUNCTION AND CHRONIC INDUCIBLE ATRIAL FIBRILLATION IN A SWINE MODEL	40
MP-470554-005 VERY SLOW ATRIOVENTRICULAR NODE REENTRY TACHYCARDIA MASQUERADING AS JUNCTIONAL RHYTHM: MECHANISM AND ELECTROPHYSIOLOGIC CHARACTERISTICS	39
PO-06-072 BIPOLAR ABLATION FOR SEPTAL VENTRICULAR TACHYCARDIA IN A PATIENT WITH CARDIAC SARCOIDOSIS	37
MP-483493-004 SUPERIORITY OF LONG-DURATION RADIOFREQUENCY ABLATION TO THE USE OF HALF-NORMAL SALINE IRRIGATION IN INCREASING LESION SIZE	37
PO-06-125 ZERO-FLUOROSCOPY CATHETER ABLATION IN PREGNANT: EVALUATION OF SAFETY, FEASIBILITY AND EFFICACY	36
PO-06-117 CLINICAL OUTCOMES OF PROSPECTIVE COMPUTATIONAL 12-LEAD ECG MAPPING GUIDED PVC ABLATION	35
MP-453089-5 CLINICAL BENEFITS OF EARLY LEFT BUNDLE BRANCH PACING IN HEART FAILURE WITH MILDLY REDUCED EJECTION FRACTION AND LEFT BUNDLE BRANCH BLOCK	34
Anatomy terminology—Note from the Editors	34
MP-453092-7 THE IMPACT OF ELECTROANATOMICAL MAPPING AND VT SUBSTRATE ABLATION ON PRIMARY AND SECONDARY PREVENTION ICD INDICATION IN PATIENTS WITH REPAIRED TETRALOGY OF FALLOT	34
PO-03-121 THE EFFECT OF DIAGNOSIS TO ABLATION TIME IN PATIENTS UNDERGOING CATHETER ABLATION FOR PERSISTENT ATRIAL FIBRILLATION	34
PO-02-156 THE RISE OF LEFT BUNDLE BRANCH AREA "PACE AND ABLATE"; AV NODAL ABLATION OUTCOMES, WHERE ARE WE NOW?	34
PO-02-081 EXPLORING THE ROLE OF HEART-TORSO GEOMETRY IN NON-INVASIVE ELECTROCARDIOGRAPHIC IMAGING ACCURACY AND POTENTIAL GEOMETRIC CALIBRATION TECHNIQUES	34
PO-05-106 THREE-DIMENSIONAL INTRACARDIAC ECHOCARDIOGRAPHY TO GUIDE LEFT ATRIAL APPENDAGE AND PERI-DEVICE LEAK CLOSURE: FEASIBILITY OF RIGHT-SIDED IMAGING	33
PO-01-103 IMPACT OF FILTERED IMPEDANCE DROP ON ATRIAL LESION SIZE PREDICTION	33
PO-01-180 MECHANISMS OF PULMONARY ARTERIAL HYPERTENSION-INDUCED ATRIAL FIBRILLATION IN THE RIGHT HEART: INSIGHTS FROM MULTI-SCALE MODELS OF THE HUMAN ATRIA	33
A troubling tachycardia	32
Association between modifiable risk factors and bradyarrhythmia: A Mendelian randomization study	32
Electroanatomic localization of idiopathic ventricular arrhythmia origins in the left ventricular outflow tract	32
Delta QRS and outcomes post CRT in the Resynchronization-Defibrillation for Ambulatory Heart Failure Trial	32
Novel electrocardiographic observations during left bundle branch area pacing: Multiple QRS transition, supernormality, concealed capture, virtual electrode effect, and other phenomena	32
Burden-based outcomes after atrial fibrillation ablation: A 4-year continuous monitoring study	32
Artificial intelligence for detection of ventricular oversensing: Machine learning approaches for noise detection within nonsustained ventricular tachycardia episodes remotely transmitted by pacemaker	32
PO-02-175 AI ENABLES SIGNIFICANT REDUCTION OF CLINIC REVIEW BURDEN FOR LEGACY ICMS	32
Performance of cardiac implantable electronic devices in detecting premature ventricular contraction burden	31
PO-01-181 A TOPSY TURVY CASE OF GADOLINIUM-BASED CONTRAST AGENT INDUCED QTC PROLONGATION AND TORSADES DE POINTES	31
PO-620-02 NITRIC OXIDE RELEASING PACING LEAD TO PREVENT INFECTION IN CARDIAC PACING	31
Type 3 long QT syndrome: Is the effectiveness of treatment with beta-blockers population-specific?	31
MP-470544-008 AV MIRRORING IN SILICONE PACING LEADS WITH TRIBOLOGICAL WEAR – A CASE SERIES	31
Risk factors associated with ventricular fibrillation during first ST-elevation myocardial infarction: Individual participant data analysis of 3 prospective case-control studies	30
Alert notifications for impending patient demise—Widening the powers of automatic remote monitoring of cardiac implantable electronic devices	30
Clinical utility of QRS duration normalized to left ventricular volume for predicting cardiac resynchronization therapy efficacy in patients with “mid-range” QRS duration	30
Comparison of left atrial appendage occlusion using transesophageal echocardiography vs 3-dimensional intracardiac echocardiography: Insights from a single-center NCDR registry	30
Long-term outcomes of left bundle branch area pacing compared with right ventricular pacing in TAVI patients	30
Pulsed field ablation for incessant scar-related ventricular tachycardia: First US report	30
PO-05-310 SOCIODEMOGRAPHIC AND GENDER DISPARITIES IN ATRIAL FLUTTER ABLATION RATES: A NATIONWIDE STUDY OF THE USA	29
PO-FPI-294 IMPACT OF ORAL ANTICOAGULANT DISCONTINUATION ON QUALITY OF LIFE IN PATIENTS AFTER SUCCESSFUL ATRIAL FIBRILLATION ABLATION: RESULTS FROM THE ALONE-AF TRIAL	29
PO-05-324 ONE YEAR FOLLOW UP COSTS OF RF VS. PFA FOR ATRIAL FIBRILLATION ABLATION	28
PO-02-333 ATRIAL GENE THERAPY TARGETING PARASYMPATHETIC SIGNALING RESULTS IN ELECTROGRAM RECURRENCE INCREASE INDICATING STABILIZATION OF ROTATIONAL DRIVERS IN ATRIAL FIBRILLATION CANINE MODEL	28
CE-534534-005 LONG-TERM PERFORMANCE OF DIFFERENT TREATMENT APPROACHES IN BRUGADA SYNDROME	28
PO-01-205 LEFT LATERAL PULSE GENERATOR PLACEMENT RECOMMENDATIONS FOR THE PARASTERNAL EV-ICD SYSTEM	28

PO-02-163 IMPACT OF TRANSTHORACIC ECHOCARDIOGRAPHIC PARAMETERS ON THE RISK FOR LEFT ATRIAL APPENDAGE THROMBUS: A RETROSPECTIVE COHORT STUDY	28
PO-04-255 TRAMETINIB AS POTENTIAL OFF-LABEL THERAPY TO PREVENT DISEASE IN A MOUSE MODEL OF SARCOMERIC HYPERTROPHIC CARDIOMYOPATHY	28
PO-03-304 INTRACARDIAC ELECTROGRAM RECORDING OF BACHMANN'S BUNDLE DURING INTERMITTENT INTERATRIAL BLOCK IN A PATIENT WITH VARYING P WAVE MORPHOLOGIES: LOCALIZING THE SITE OF INTERATRIAL CONDUCTION DEL	28
PO-01-254 REAL WORLD DATA OF CARDIAC RESYNCHRONIZATION THERAPY AMONG MID-RANGE QRS DURATION USING THE JPN-CRT DATA IN ASIA	28
PO-02-239 IT’S JUST, A LITTLE TOUCH…PERMANENT MECHANICAL EFFECT ON AN UNUSUAL ATRIAL FOCUS IN A CHILD	28
PO-04-029 VERY HIGH POWER VS. HIGH POWER SHORT DURATION CATHETER ABLATION OF PAROXYSMAL ATRIAL FIBRILLATION – PROCEDURAL RESULTS FROM A RANDOMIZED TRIAL	27
PO-01-041 SAFETY OF THE USE OF THE VARIABLE LOOP CIRCULAR CATHETER FOR PATIENTS WITH ATRIAL FIBRILLATION AND CARDIAC DEVICES	27
PO-02-244 SILENCING THE VAGUS: INTRACARDIAC ECHO GUIDED CARDIONEUROABLATION FOR MALIGNANT BRADYCARDIA AFTER TRAUMATIC BRAIN INJURY	27
PO-03-012 PATIENT-LEVEL OPTIMIZATION OF LOOP RECORDER TRANSMISSIONS: A LONGITUDINAL ANALYSIS OF 26 PATIENTS ACHIEVING 71% REDUCTION	27
PO-03-267 FEASIBILITY AND SHORT-TERM OUTCOMES OF DISTAL HIS BUNDLE PACING	27
PO-FPI-017 ESTIMATING APNEA HYPOPNEA INDEX USING ECG AND DEEP NEURAL NETWORKS	27
PE-534543-001 FEASIBILITY OF A MODIFIED MINIATURE DUAL CHAMBER EPICARDIAL PACING SYSTEM FOR PEDIATRIC USE	27
PO-04-149 SAFETY AND CLINICAL OUTCOMES OF AN INDEX ENDO-EPICARDIAL STRATEGY, UTILISING EPICO2,FOR ANTIARRHYTHMIC RESISTANT VENTRICULAR ARRHYTHMIAS	27
PO-CES-01 PANORAMIC OPTICAL AND VOLUMETRIC ULTRASOUND IMAGING OF ELECTROMECHANICS IN CONTRACTING HEARTS	27
PO-04-293 SAFETY AND EFFICACY OF ANTITHROMBOTIC THERAPY WITH LOW-DOSE APIXABAN AFTER WATCHMAN FLX LEFT ATRIAL APPENDAGE OCCLUSION DEVICE IMPLANTATION	27
PO-05-276 PROCEDURAL & CLINICAL OUTCOMES OF ADDITIONAL ATRIAL ARRHYTHMIAS ABLATED DURING PULSED FIELD ABLATION OF PAROXYSMAL AND PERSISTENT ATRIAL FIBRILLATION	26
PO-FPII-311 LEAD V8 AS A SIMPLE NON-INVASIVE TOOL FOR ASSESSING LV ACTIVATION DELAY AND GUIDING LEAD PLACEMENT ACROSS CONDUCTION ABNORMALITIES	26
PO-04-120 CATHETER ABLATION OF VENTRICULAR TACHYCARDIAS IN STRUCTURAL HEART DISEASE USING A DUAL-ENERGY LATTICE-TIP FOCAL CATHETER	26
PO-CES-08 AI-ENABLED ECG PREDICTS FUTURE ONSET OF ATRIAL ARRHYTHMIAS IN PEDIATRIC AND CONGENITAL HEART DISEASE	26
PO-04-013 NATIONWIDE SAFETY ASSESSMENT OF OVER 20,000 PULSED FIELD AND 10,000 THERMAL ABLATIONS FOR ATRIAL FIBRILLATION IN THE UNITED STATES	26
PO-04-254 A HUMAN IPSC-DERIVED SINOATRIAL NODE ORGANOID MODEL RECAPITULATES FIBROSIS-DRIVEN SICK SINUS SYNDROME AND IDENTIFIES TANSHINONE IIA AS A POTENTIAL THERAPEUTIC AGENT	26
PO-FPI-016 PROGNOSTIC SIGNIFICANCE OF AF BURDEN QUANTIFIED BY CONTINUOUS REMOTE MONITORING IN PATIENTS WITH CARDIAC IMPLANTABLE DEVICES	26
PO-01-209 TRICUSPID VALVE FUNCTION AFTER HELIX-FIXATION LEADLESS PACEMAKER IMPLANTATION: A SINGLE-CENTER EXPERIENCE	26
PO-02-093 DOES ATRIAL ECTOPY PREDICT ATRIAL FIBRILLATION RECURRENCE POST-ABLATION? A RETROSPECTIVE OBSERVATIONAL STUDY	25
PO-05-269 POST-ABLATION SCAR BURDEN DISCRIMINATES RECURRENCE PATTERN: ATRIAL FLUTTER VS ATRIAL FIBRILLATION	25
PO-02-101 NUMBER NEEDED TO ENTRAIN AND PROXIMITY TO VENTRICULAR TACHYCARDIA RE-ENTRANT CIRCUITS	25
PO-03-197 THE COMPETING RISK OF ARRHYTHMIC EVENTS AND NON-ARHYTHMIC MORTALITY BY AGE: ANALYSIS FROM THE APPRAISE-ATP TRIAL	25
PO-02-035 RIGHT ATRIAL CARDIOMYOPATHY AS THE DOMINANT STRUCTURAL PREDICTOR OF AF RECURRENCE AFTER ABLATION	25
PO-03-151 ARRHYTHMIA AND QT PROLONGATION PROFILE OF OSIMERTINIB IN EGFR-MUTATED LUNG CANCER: A PROPENSITY-MATCHED REAL-WORLD ANALYSIS	24
PO-05-038 ANTI-INFLAMMATORY AND AUTONOMIC EFFECTS OF BAROREFLEX ACTIVATION THERAPY IN HFREF: A CASE SERIES	24
PO-01-009 SAFETY OF PULSED FIELD ABLATION FOR ATRIAL FIBRILLATION IN PATIENTS WITH CARDIAC IMPLANTABLE ELECTRONIC DEVICES: INSIGHTS FROM THE PROSPECTIVE MULTICENTER DISRUPT-AF REGISTRY	23
PO-05-040 ELECTRICAL DATA AND EGM MORPHOLOGY WITH ACUTE THROMBUS FORMATION ON HELIX OF LEADLESS VENTRICULAR PACEMAKERS	23
PO-02-186 VENTRICULAR ARRHYTHMIA ORIGINATING FROM THE EPICARDIAL ASPECT OF THE RIGHT VENTRICULAR APEX: A CASE REPORT	23
PO-04-022 COMPREHENSIVE RESULTS FROM AN ITERATIVE FIRST-IN-HUMAN INTEGRATED INTRACARDIAC ECHOCARDIOGRAPHY TRIAL	23
PE-534544-005 LONG-TERM ARRHYTHMIA AFTER CONE REPAIR OF EBSTEIN ANOMALY IN PEDIATRIC PATIENTS	23
PO-02-103 LONG-TERM FOLLOW-UP OF CARDIAC SYMPATHETIC DENERVATION FOR REFRACTORY VENTRICULAR ARRHYTHMIAS: A SINGLE-CENTER RETROSPECTIVE STUDY	23
PO-05-019 BEYOND VASOSPASM: PVC-INITIATED POLYMORPHIC VENTRICULAR TACHYCARDIA AND VENTRICULAR FIBRILLATION STORM AFTER 5-FLUOROURACIL THERAPY	23
PO-03-071 GLP-THERAPY USE AND LOWER BRADYCARDIA RISK IN DIABETES: INSIGHTS FROM A LARGE REAL-WORLD COHORT	23
PO-03-235 OUTCOMES OF CONDUCTION SYSTEM PACING IN COMPLETE HEART BLOCK: EVIDENCE FROM A LARGE REAL-WORLD COHORT	23
PO-03-061 PREDICTION OF ATRIAL FIBRILLATION FROM 10-SECOND AND 60-SECOND AMBULATORY ECG SEGMENTS USING A SELF-SUPERVISED FOUNDATIONAL MODEL	23
PO-02-203 SUCCESSFUL ABLATION OF ELECTRICAL STORM IN BURNT-OUT ARVC WITHOUT HEMODYNAMIC SUPPORT	22
PO-01-331 A PROSPECTIVE MULTICENTER STUDY OF MAPPING AND ABLATION OF FOCAL DRIVERS IN REPEAT ATRIAL FIBRILLATION ABLATION	22
PO-03-063 NOVEL SOFTWARE PLATFORM UTILIZES IMPLANTABLE CARDIAC MONITOR SECGS FOR EXTENDED QTC AND RHYTHM SURVEILLANCE IN AF PATIENTS ON ANTIARRHYTHMIC DRUGS: A CLINICAL PILOT	22
PO-02-332 ELEVATED IGE IS ASSOCIATED WITH ATRIAL FIBRILLATION AND PROMOTES CARDIAC SYMPATHETIC REMODELING: A TRANSLATIONAL STUDY	22
PO-02-288 ADVANCED AGE PROMOTES ATRIAL ECTOPY AND ATRIAL FIBRILLATION STABILIZATION: THE ROLE OF ACTIVATED COAGULATION FACTORS AND THE ATRIAL INFLAMMASOME	22
PO-04-329 IMPACT OF VERICIGUAT ON VENTRICULAR AND ATRIAL ARRHYTHMIC OUTCOMES IN PATIENTS WITH HEART FAILURE AND REDUCED EJECTION FRACTION: A SYSTEMATIC REVIEW AND META-ANALYSIS	22
PO-02-047 HIGHER DIETARY FIBER INTAKE IS ASSOCIATED WITH LOWER RESTING HEART RATE AND REDUCED TACHYCARDIA PREVALENCE IN U.S. ADULTS: ANALYSIS OF NHANES 2017–2018	22
PO-01-337 NONINVASIVE NEUECG CAPTURES DIET INDUCED SYMPATHETIC DYSFUNCTION WITH HISTOLOGIC CONFIRMATION IN THE STELLATE GANGLION	22
PO-05-017 A MASSIVE STEMI: OR A CATASTROPHIC CONSEQUENCE TO ABLATION?	22
PO-05-283 FIRST-IN-HUMAN EXPERIENCE AND SIX-MONTH OUTCOMES USING A NOVEL SMALL-BALLOON PULSED-FIELD ABLATION CATHETER IN PERSISTENT ATRIAL FIBRILLATION	22
PO-FPII-298 NOVEL FIXED HELIX STYLET DRIVEN LEAD FOR LBBAP: SHORT-TERM SAFETY AND PERFORMANCE OF THE SOLIA CSP S PACEMAKER LEAD	22
PO-02-081 REDUCTION IN ARIAL TACHYCARDIA/ATRIAL FIBRILLATION IN SUSTAINED ATRIAL FIBRILLATION PATIENTS AFTER ATRIOVENTRICULAR JUNCTION ABLATION: A RETROSPECTIVE REAL-WORLD ANALYSIS	21
Reply to the Editor — Risk of atrial arrhythmias in arrhythmogenic right ventricular cardiomyopathy patients undergoing ventricular tachycardia ablation	21
PO-01-146 SUCCESSFUL MANAGEMENT OF MULTIFOCAL ATRIAL TACHYCARDIA WITH TRAMETINIB IN COSTELLO SYNDROME	21
Managing vagal responses induced by pulsed field ablation: Go right first?	21
PO-03-119 EARLY VENTRICULAR ARRHYTHMIA RISK AFTER ACUTE PERICARDITIS: A PROPENSITY MATCHED COHORT ANALYSIS	21
Age-stratified outcomes of transvenous lead extraction: A 5090-patient experience from the ExTRACT registry	21
PO-FP-083 ARRHYTHMIC EVENT RISK AND NEONATAL OUTCOMES IN PREGNANT AND POSTPARTUM CPVT PATIENTS	21
Diltiazem, direct oral anticoagulants, and risk of major bleeding in patients with atrial fibrillation	21
PO-03-213 CLINICAL IMPACT OF LEADLESS PACEMAKER IMPLANTATION ON TRICUSPID REGURGITATION	21
Heart Rhythm 2026 Abstract Reviewers	21
Ventricular arrhythmias in patients with hypertrophic cardiomyopathy: Prevalence, distribution, predictors, and outcome	21
Defining the holy grail of left bundle branch area pacing—does the pulse width matter?	21
PO-05-200 FEASIBILITY AND ACCEPTABILITY OF A SELF-CARE INTERVENTION FOR IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) PATIENTS: A “SYSTEMS CHECK”	21
CI-534529-001 RETRIEVAL EXPERIENCE OF DUAL-CHAMBER, HELIX-FIXATION LEADLESS PACEMAKERS	21
Association of frailty with outcomes of patients undergoing transvenous lead removal for cardiac implantable electronic device infections in the United States	21
PO-02-192 OUTCOMES OF LEFT ATRIAL APPENDAGE OCCLUSION IN PATIENTS WITH HEART FAILURE: A 5-YEAR PROPENSITY MATCHED ANALYSIS	20
PO-02-038 LACK OF ATRIAL BRANCH PERFUSION DURING ACUTE ISCHEMIA IS NOT ASSOCIATED WITH NEW-ONSET ATRIAL FIBRILLATION DURING STEMI	20
PO-04-028 PULSED FIELD ABLATION FOR PULMONARY VEIN ISOLATION WITH OR WITHOUT POSTERIOR WALL ISOLATION IN PATIENTS WITH PAROXYSMAL ATRIAL FIBRILLATION: A MULTICENTER RETROSPECTIVE STUDY	20
PO-02-088 THE IMPACT OF POSTOPERATIVE ATRIAL FIBRILLATION AFTER CARDIAC SURGERY	20
HF-499653-005 CHARACTERIZATION OF RIGHT BUNDLE BRANCH BLOCK WITH INVASIVE MAPPING: IMPLICATIONS FOR CONDUCTION SYSTEM PACING	20
PO-05-076 GENETIC DEPENDENCY OF ATRIAL FIBRILLATION-ASSOCIATED RISK GENES ACROSS TISSUE TYPES: DISCOVERING NOVEL THERAPEUTIC TARGETS	20
PO-05-214 THE RELATIONSHIP BETWEEN WIDE ANTRAL CIRCUMFERENTIAL ABLATION LINE LENGTH AND RECURRENCE OF ATRIAL FIBRILLATION POST-PULMONARY VEIN ISOLATION	20
PO-05-020 ARTERIAL BAROREFLEX DESENSITIZATION IS THE MECHANISM OF SYMPATHETIC OVERLOAD AND PARASYMPATHETIC SUPPRESSION IN PREMATURE VENTRICULAR CONTRACTION-INDUCED CARDIOMYOPATHY	20
PO-01-064 CONDUCTION SYSTEM PACING TO RESYNCHRONIZE AND IMPROVE THE SYSTOLIC PERFORMANCE OF THE SYSTEMIC RIGHT VENTRICLE IN A PATIENT WITH CONGENITALLY CORRECTED TRANSPOSITION OF THE GREAT ARTERIES	20
PO-01-103 PFA TO THE RESCUE: TERMINATION OF RF RESISTANT RVOT VT WITH A SINGLE PFA APPLICATION	20
EN-499638-002 PHARMACOLOGIC RESCUE OF LOSS-OF-FUNCTION CARDIAC SODIUM CHANNELOPATHIES	20
PO-04-016 CALCULATION OF LOADING DOSE OF HEPARIN DURING ATRIAL FIBRILLATION ABLATION IN PATIENTS RECIEVING UNINTERRUPTED DIRECT ORAL ANTICOAGULANT AGENTS	20
PO-04-145 IMPACT OF TIME FROM ATRIAL FIBRILLATION DIAGNOSIS TO ABLATIVE THERAPY ON DEATH AND HOSPITALIZATION IN HEART FAILURE WITH PRESERVED EJECTION FRACTION: RESULTS BY AGE AND SEX FROM THE INTERMOU	19
PO-CES-01 OPTOGENETICS FOR INVESTIGATION OF ARRHYTHMIA MECHANISMS AND TREATMENTS IN A HUMANIZED RECELLULARIZED ATRIAL MODEL	19

PO-03-073 1-YEAR AND 3-YEAR OUTCOME COMPARISON BETWEEN RADIOFREQUENCY AND CRYOBALLOON ABLATION IN ATRIAL FIBRILLATION	19
PO-FP-023 ASSOCIATIONS BETWEEN DEVICE-MEASURED 24-HOUR MOVEMENT BEHAVIORS AND CARDIAC CONDUCTION DISEASE IN THE UK BIOBANK: A PROSPECTIVE COHORT STUDY	19
PO-05-132 SGLT2 INHIBITORS ATTENUATE ATRIAL CARDIOMYOPATHY AND REDUCE AF SUSCEPTIBILITY IN NPPA KNOCK-IN RATS	19
PO-07-031 UNCOVERING WHAT IS RIGHT IN FRONT OF US: QDOT MICRO™ FOR ACCESSORY PATHWAY ABLATION	19
PO-02-017 POSTPARTUM DIRECT ORAL ANTICOAGULANTS OR ASPIRIN IN PREGNANT WOMEN WITH ATRIAL FIBRILLATION: A PROPENSITY SCORE-MATCHED ANALYSIS	19
PO-05-031 CARDIAC SYMPATHETIC NEUROPATHOLOGY SUPPORTS THE MULTICELLULARITY OF ARRHYTHMOGENIC CARDIOMYOPATHY	19
PO-04-170 WITHDRAWN	19
PO-06-128 SHORT-TERM OUTCOMES AND PERFORMANCE OF DUAL-CHAMBER LEADLESS PACEMAKERS: A SINGLE-CENTRE EXPERIENCE WITH 60 PATIENTS	19
PO-03-081 VISUALIZATION AND CHRONIC ASSESSMENT OF ELECTRICAL FIELD TAGS FOR PULSED FIELD ABLATION OF PULMONARY VEINS WITH THE SECOND-GENERATION PENTASPLINE CATHETER	19
PO-06-033 LONG-TERM OUTCOMES OF TRIPLE-SITE VERSUS DUAL-SITE CARDIAC RESYNCHRONIZATION THERAPY USING TEMPORARY PACING TO GUIDE INDIVIDUALIZED IMPLANTATION	18
PO-02-201 LONG-TERM USE OF ORAL ANTICOAGULATION AFTER WATCHMAN IMPLANTATION	18
PO-07-107 CRYOBALLON PULMONARY VEIN ISOLATION (PVI) IN SITUS AMBIGUOUS AND DEXTROCARDIA	18
PO-06-006 HIGH ATRIAL SEPTAL IMPLANTS DEMONSTRATE REDUCED ACUTE INACTIVATION RATES AND IMPROVED AV CONDUCTION WHEN COMPARED TO APPENDAGE IMPLANTS	18
PO-06-070 CURRENT OF INJURY ON THE RIGHT VENTRICULAR ENDOCARDIUM BEFORE ENTRAPMENT OR SUCCESSFUL PLACEMENT OF THE LEFT BUNDLE BRANCH AREA PACING LEAD	18
PO-06-191 PREDICTORS OF PACEMAKER DEPENDENCY FOLLOWING TRANSCATHETER AORTIC VALVE IMPLANTATION	18
PO-07-035 DEEP LEARNING-BASED PREDICTION OF AVNRT ABLATION TARGETS FROM INTRACARDIAC ELECTROGRAMS	18
PO-06-032 LV SIZE: AN ANONYMOUS MODULATOR OF ELECTRICAL OPTIMIZATION IN CRT	18
PO-06-203 IMPLANTABLE CARDIOVERTER DEFIBRILLATOR FAILURE DUE TO HIGH-VOLTAGE IMPEDANCE ABNORMALITY CAUSING MONOPHASIC SHOCKS AND DEFIBRILLATION FAILURE	18
PO-02-044 EFFICACY AND DRUG-RELATED COMPLICATIONS OF ANTICHOLINERGIC DRUGS FOR VAGAL REACTION PREVENTION DURING PULSED FIELD ABLATION	18
PO-07-064 STELLATE GANGLION BLOCK AS AN ADJUNCT TREATMENT OF DRUG-REFRACTORY ELECTRIC STORM: A PERSPECTIVE OF A TERTIARY CENTER	18
PO-02-118 CLUSTERING BASED ON CARDIAC AND BRAIN CENTRAL AUTONOMIC NETWORK DATA STRATIFIES ATRIAL FIBRILLATION PATIENTS BY COMORBID DEPRESSION AND STROKE RISK	18
PO-04-010 TEMPORAL SEQUENCE OF OBSTRUCTIVE SLEEP APNEA AND ATRIAL FIBRILLATION DEVELOPMENT IMPACTS THE PROGNOSIS AND THE INCIDENCE OF MAJOR CARDIOVASCULAR EVENTS	18
PO-07-070 STELLATE GANGLION BLOCK IN THE MANAGEMENT OF EMERGENT VENTRICULAR ARRHYTHMIAS: OUTCOMES FROM A SINGLE CANADIAN CENTER	18
PO-03-208 COMPARISON OF LESION FORMATION WITH TEMPERATURE CONTROLLED ABLATION USING QDOT CATHETER	17
CI-482892-002 DEFIBRILLATION SUCCESS WITH A SECOND GENERATION INTERCOSTAL EXTRAVASCULAR ICD LEAD AND COMMERCIALLY AVAILABLE LEFT PECTORAL PULSE GENERATORS	17
PO-691-04 SATURATED FATTY ACIDS DIFFERENTIALLY MODULATE ION CHANNEL AND STRUCTURAL REMODELING IN MATURE IPSC-DERIVED ATRIAL CARDIOMYOCYTES LEADING TO OBESITY-INDUCED ATRIAL FIBRILLATION	17
PO-624-07 ADVERSE EVENTS OF PENTARAY CATHETER VERSUS HIGH DENSITY GRID CATHETER : A REVIEW OF MAUDE DATABASE	17
PO-07-216 EVALUATING SAFETY PROFILE AND LEARNING CURVE WITH A PULSED FIELD ABLATION VARIABLE LOOP CIRCULAR CATHETER IN PROCEDURES FOR AF: OBSERVATIONS FROM A PROSPECTIVE, MULTICENTER, POSTMARKET CLINI	17
Atrial fibrillation’s hidden compass: The left atrium and the future of risk stratification	17
Endothelial function improvement and the outcomes after catheter ablation of persistent atrial fibrillation	17
PO-634-05 RATES AND PREDICTORS OF HOSPITAL AND EMERGENCY DEPARTMENT CARE AFTER CATHETER ABLATION OF ATRIAL FIBRILLATION	17
PO-653-02 MORTALITY RELATED TO ANTIARRHYTHMIC CHOICE AMONG PATIENTS WITH ATRIAL FIBRILLATION AND LEFT VENTRICULAR HYPERTROPHY	17
PO-06-090 THE INCIDENCE OF FAILURE OF REMAINING FUNCTIONAL LEADS AND NEWLY IMPLANTED LEADS AFTER TRANSVENOUS LEAD EXTRACTION	17
MP-470551-004 EARLY ROLE OF NEUTROPHILS IN THE PATHOGENESIS OF ARRHYTHMOGENIC CARDIOMYOPATHY	17
PO-673-06 CARDIAC RESYNCHRONIZATION WITH LEFT BUNDLE AREA PACING COMPARED TO HIS BUNDLE AND BIVENTRICULAR PACING; AN ACUTE ELECTRICAL AND HAEMODYNAMIC WITHIN PATIENT COMPARISON	17
PO-631-06 ARTIFICIAL INTELLIGENCE-ENABLED MODEL FOR EARLY DETECTION OF LEFT VENTRICULAR HYPERTROPHY AND MORTALITY PREDICTION IN YOUNG TO MIDDLE-AGED ADULTS	17
PO-646-07 KCNH2 VARIANTS IDENTIFIED AS PATHOGENIC, DAMAGING, AND DYSFUNCTIONAL DO NOT RELIABLY IDENTIFY LONG QT SYNDROME IN LARGE PATIENT BIOBANK	17
CI-523-01 CONDUCTION SYSTEM PACING VERSUS CONVENTIONAL PACING IN PATIENTS UNDERGOING AV NODE ABLATION: NON-RANDOMIZED, ON-TREATMENT COMPARISON	16
PO-716-02 SHORT TERM READMISSION RATES AND CLINICAL OUTCOMES OF ANTICOAGULATION VERSUS WATCHMAN DEVICE IN OCTOGENARIANS	16
PO-628-07 LEFT BUNDLE-BRANCH PACING POST-ATRIOVENTRICULAR JUNCTION ABLATION FOR ATRIAL FIBRILLATION: PROPENSITY-SCORE MATCHING WITH HIS BUNDLE PACING	16
PO-706-05 DECREASE IN ACTIVITY OF DAILY LIVING DURING THE COVID-19 PANDEMIC CORRELATES WITH A DECREASE IN BIOMETRIC VARIABLES	16
PO-701-03 ANATOMICAL CONSIDERATIONS AND CLINICAL INTERPRETATION OF PRONE 12-LEAD ECG: INSIGHTS FROM A MULTICENTER PROSPECTIVE STUDY	16
EP News: Pediatric and Congenital Electrophysiology	16
PO-660-04 THE NARROW AND STRAIGHT OF COMPARING CONSISTENCY OF LIVE PROPAGATION VECTORS FROM MULTI-ELECTRODE ARRAY CATHETERS	16
PO-636-08 PULSE FIELD ABLATION FOR PULMONARY VEIN ISOLATION: ACUTE RESULTS FROM A MULTICENTRIC REGISTRY	16
CI-524-04 RISK OF VENTRICULAR ARRHYTHMIAS FOLLOWING IMPLANTABLE CARDIOVERTER DEFIBRILLATOR GENERATOR CHANGE IN PATIENTS WITH RECOVERED EJECTION FRACTION: IMPLICATIONS FOR SHARED DECISION MAKING	16
CA-527-03 DOES HIGH POWER - SHORT RADIOFREQUENCY ABLATION PRODUCE WIDER ATRIAL LESIONS ?	16
Supraventricular tachycardia with double trouble	16
PO-701-08 A DATA-DRIVEN PREPROCESSING FRAMEWORK FOR ATRIAL FIBRILLATION INTRACARDIAC ELECTROCARDIOGRAMS ANALYSIS	16
HF-566-02 PREDICTED RISK OF VENTRICULAR ARRHYTHMIA IN INDIVIDUALS WITH DESMOSOME GENE VARIANTS IDENTIFIED VIA POPULATION GENOMIC SCREENING	16
PO-668-06 AUTOMATED QUANTIFICATION OF ABNORMAL LOW-AMPLITUDE QRS PEAKS FROM HIGH-RESOLUTION ECGS PREDICTS LATE VENTRICULAR ARRHYTHMIAS IN HYPERTROPHIC CARDIOMYOPATHY: A 5-YEAR PROSPECTIVE MULTICENTER	16
PO-617-02 A HIDDEN STRATIFICATION PROBLEM IN NEURAL ECG ANALYSIS	16
PO-711-01 CATHETER ABLATION OF THE MITRAL ISTHMUS LINE USING THE NOVEL DIAMONDTEMP ABLATION SYSTEM: FIRST EXPERIENCE USING TWO DIFFERENT ABLATION PROTOCOLS	16
CE-521-02 REPRODUCIBILITY OF CARDIAC GANGLIONATED PLEXUS LOCALISATION USING A NOVEL CURRENT-CONTROLLED HIGH FREQUENCY STIMULATOR	16
BS-516-01 A NOVEL COMPUTATIONAL-AI FRAMEWORK TO DETECT SITES OF ORIGINS OF SCAR-RELATED VENTRICULAR TACHYCARDIA FROM IMPLANTED DEVICE ELECTROGRAMS	16
CI-525-03 DEVICE-TO-DEVICE COMMUNICATION FOR A NOVEL DUAL-CHAMBER LEADLESS PACEMAKER SYSTEM: RELIABILITY OF MAINTAINING ATRIOVENTRICULAR SYNCHRONY IN AN OVINE MODEL OF AV CONDUCTION BLOCK	16
PE-565-01 PROGRAMMED VENTRICULAR STIMULATION AS AN ADDITIONAL PRIMARY PREVENTION RISK STRATIFICATION TOOL IN ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY: A MULTINATIONAL STUDY	16
PO-03-051 EXPEDITED SAME DAY DISCHARGE PROTOCOL IS SAFE FOR PATIENTS UNDERGOING CARDIAC IMPLANTABLE ELECTRONIC DEVICE (CIED) IMPLANTATION	15
PO-710-02 PATIENT COMORBIDITIES AND ABLATION TECHNIQUE ARE IMPORTANT DETERMINANTS OF FIRST PASS PULMONARY VEIN ISOLATION	15
PO-645-05 CARDIAC ALTERNANS AS A BIOMARKER OF DYNAMIC ELECTROPHYSIOLOGICAL CHANGES IN ARRHYTHMOGENIC ISCHEMIC SUBSTRATES	15
PO-685-07 AREA WEIGHTED UNIPOLAR VOLTAGE TO PREDICT HEART FAILURE DEATH IN PATIENTS WITH ISCHEMIC CARDIOMYOPATHY AND VENTRICULAR TACHYCARDIA	15
PO-04-144 IMPACT OF AGE ON ATRIAL ARRHYTHMIA OUTCOMES AFTER PERCUTANEOUS ASD CLOSURE	15
PO-615-05 ACACETIN, A POTENT TRANSIENT OUTWARD CURRENT BLOCKER, MAY BE A NOVEL THERAPEUTIC FOR KCND3-ENCODED KV4.3 GAIN-OF-FUNCTION-ASSOCIATED J-WAVE SYNDROMES	15
EP News: Pediatric and Congenital Electrophysiology	15
HP-574-02 PROPORTION OF WOMEN AND REPORTING OF OUTCOMES BY SEX IN CONTEMPORARY CLINICAL TRIALS OF ATRIAL FIBRILLATION	15
PO-657-08 USE OF A PERIPHERAL BALLOON DILATATION CATHETER FOR TRANSSEPTAL PUNCTURE IN A PATIENT WITH ATRIAL FIBRILLATION AND AN ATRIAL SEPTAL OCCLUSION DEVICE	15
Heart Rhythm 2022 Program Committee	15
PO-658-08 RISK OF LONG-TERM CARDIOVASCULAR DEATH IN PATIENTS WITH MILDLY REDUCED EJECTION FRACTION AFTER ACUTE MYOCARDIAL INFARCTION	15
Leadless pacing after transvenous lead extraction: Are we out of the woods?	15
PO-03-055 INCIDENCE OF INAPPROPRIATE PAUSE DETECTION WITH REMOTE CARDIAC MONITORING BY INSERTABLE CARDIAC MONITOR, A REAL-WORLD STUDY	15
CA-530-03 TAILORED ABLATION INDEX BASED ON LEFT ATRIAL WALL THICKNESS ASSESSED BY COMPUTED TOMOGRAPHY FOR PULMONARY VEIN ISOLATION IN PATIENTS WITH ATRIAL FIBRILLATION	15
PO-03-093 EFFECT OF CATHETER ABLATION FOR ATRIAL FIBRILLATION ON LEFT ATRIAL FUNCTION AND LEFT VENTRICULAR DIASTOLIC FILLING	15
PO-635-05 VENTRICULAR ARRHYTHMIA ABLATION WITHOUT FLUOROSCOPIC UTILIZATION - A SINGLE CENTER EXPERIENCE	15
PO-03-158 PEDIATRIC CARDIAC SCREENING DATA WAREHOUSE: A NATIONAL PUBLIC HEALTH RESOURCE	15
CE-538-01 TRANSCATHETER LEAK OCCLUSION WITH ENDOVASCULAR COILS FOLLOWING LEFT ATRIAL APPENDAGE CLOSURE: PROCEDURAL SUCCESS AND OUTCOMES BEFORE AND AFTER LEAK CLOSURE	15
PO-670-07 OPTIMISING ANTITHROMBOTIC AGENTS IN PATIENTS UNDERGOING LEFT ATRIAL APPENDAGE OCCLUSION	15
PO-03-222 CURRENT TRENDS AND OUTCOMES OF SUDDEN CARDIAC ARREST IN YOUNG ADULTS IN THE USA: INSIGHTS FROM THE NATIONAL INPATIENT SAMPLE	15
Fifty years later, I was the recipient of the medical innovation I invented	15
PO-712-03 RATE OF 30-DAY READMISSION AND ECONOMIC BURDEN IN PATIENTS WITH SICK SINUS SYNDROME WITH COEXISTING CHRONIC DIASTOLIC HEART FAILURE WHO UNDERWENT PACEMAKER INSERTION	15
Atrial resynchronization with Bachmann bundle pacing—time to think outside the appendage?	14
PO-03-094 IMAGE INTEGRATION IN VENTRICULAR TACHYCARDIA (VT) ABLATION USING SENSE2 PROTOCOL MAPPING	14
PO-04-110 MAPPING TRENDS IN AVNRT ABLATION: AN INTERNATIONAL ANALYSIS	14
Table of Contents	14
CE-521-01 STELLATE GANGLION INSTRUMENTATION FOR RECORDING AND STIMULATION IN PATIENTS WITH VENTRICULAR ARRHYTHMIAS. PRELIMINARY EXPERIENCE	14
The frequency of gene variant reclassification and its impact on clinical management in the inherited arrhythmia clinic	14
PO-631-02 RIGHT PRECORDIAL U WAVES IN SEVERE AORTIC STENOSIS: PREVALENCE IN A "REAL WORLD" COHORT AND DIMINUTION BY TAVR	14
PO-04-033 CARDIONEUROABLATION IN A WOMAN WITH ICTAL-INDUCED CARDIAC ASYSTOLE	14
PO-02-151 INCREASED VENTRICULAR ARRHYTHMIAS IN A MOUSE MODEL OF HYPERTROPHIC CARDIOMYOPATHY	14
PO-02-047 OUTCOMES OF CARDIOVASCULAR IMPLANTABLE ELECTRONIC DEVICE REMOVAL WITHOUT REIMPLANTATION IN PEDIATRIC PATIENTS	14
14-3-3ε/YWHAE regulates the transcriptional expression of cardiac sodium channel NaV1.5	14
PO-02-089 EMPIRIC VEIN OF MARSHALL ETHANOL INFUSION IN PATIENTS UNDERGOING REPEAT CATHETER ABLATION WITH DURABLY ISOLATED PULMONARY VEINS	14
PO-03-007 CROSS VALIDATION OF A MACHINE LEARNING ALGORITHM DESIGNED TO IDENTIFY PULMONARY VEIN SIGNALS USING COMPETING TRAINING DATA	14
PO-02-199 A NOVEL FINDING: SERUM MICRORNA-122 CORRELATES WITH LEFT ATRIAL SUBSTRATE IN PATIENTS WITH ATRIAL FIBRILLATION	14
PO-03-138 REAL-WORLD EXPERIENCE UTILIZING THE NUVISION 4D INTRACARDIAC ECHOCARDIOGRAPHY CATHETER FOR LEFT TRIAL APPENDAGE CLOSURE	14
PO-04-233 MULTIDISCIPLINARY APPROACHES TO TREAT VENTRICULAR ARRHYTHMIAS WITH RADIOABLATION AND CARDIAC SYMPATHECTOMY (MAVERICS)	14